New-generation thromboelastography: Comprehensive evaluation of Citrated and heparinized blood sample storage effect on clot-forming variables

Archives of Pathology and Laboratory Medicine

Volumn 141, Issue 4, 2017, Pages 569-577

  Dias, Joao D ^a   Haney, Elaine I ^b   Mathew, Blesy A ^b   Lopez Espina, Carlos G ^b   Orr, Adrian W ^b,c   Popovsky, Mark A ^b  

^a Clinical Marketing Haemonetics SA   (Switzerland)

^b HAEMONETICS CORPORATION   (United States)

^c Anika Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; HEPARIN; KAOLIN;

ADULT; BLOOD CLOTTING; BLOOD SAMPLING; CHEMISTRY; DRUG EFFECTS; EVALUATION STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; THROMBOELASTOGRAPHY; TIME FACTOR; YOUNG ADULT;

ADULT; BLOOD COAGULATION; BLOOD SPECIMEN COLLECTION; CITRATES; FEMALE; HEPARIN; HUMANS; KAOLIN; MALE; MIDDLE AGED; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY; TIME FACTORS; YOUNG ADULT;

EID: 85016451913     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2016-0088-OA     Document Type: Article

References (44)

1. Von Kaulla KN, Kaye H, von Kaulla E, Marchioro TL, Starzl TE. Changes in blood coagulation. Arch Surg. 1966;92(1):71-79.
2. Agarwal S, Johnson RI, Shaw M. Preoperative point-of-care platelet function testing in cardiac surgery. J Cardiothorac Vasc Anesth. 2015;29(2):333-341.
3. Gonzalez E, Moore EE, Moore HB, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays [published online ahead of print December 28, 2015]. Ann Surg. 2016;253(6):1051-1059.
4. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology [published correction appears in Eur J Anaesthesiol. 2014;31(4): 247]. Eur J Anaesthesiol. 2013;30(6):270-382.
5. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015;122(2):241-275.
6. Whiting P, Al M, Westwood M, et al. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015;19(58):1-228, v-vi.
7. Camazine MN, Hemmila MR, Leonard JC, et al. Massive transfusion policies at trauma centers participating in the American College of Surgeons Trauma Quality Improvement Program. J Trauma Acute Care Surg. 2015;78(6) (suppl 1):S48-S53.
8. Quarterman C, Shaw M, Johnson I, Agarwal S. Intra- and inter-centre standardisation of thromboelastography (TEG®). Anaesthesia. 2014;69(8):883-890.
9. Jackson GN, Ashpole KJ, Yentis SM. The TEG vs the ROTEM thromboe-lastography/thromboelastometry systems. Anaesthesia. 2009;64(2):212-215.
10. Chen A, Teruya J. Global hemostasis testing thromboelastography: old technology, new applications. Clin Lab Med. 2009;29(2):391-407.
11. Owen CA Jr. Historical account of tests of hemostasis. Am J Clin Pathol. 1990;93(4) (suppl 1):S3-S8.
12. Eckman MH, Erban JK, Singh SK, Kao GS. Screening for the risk for bleeding or thrombosis. Ann Intern Med. 2003;138(3):W15-W24.
13. Gurbel PA, Bliden KP, Tantry US, et al. First report of the point-of-care TEG: A technical validation study of the TEG-6S system [published online ahead of print April 9, 2016]. Platelets. doi:10.3109/09537104.2016.1153617.
14. Sharma AD, Al-Achi A, Seccombe JF, Hummel R, Preston M, Behrend D. Does incorporation of thromboelastography improve bleeding prediction following adult cardiac surgery? Blood Coagul Fibrinolysis. 2014;25(6):561-570.
15. Reinhofer M, Brauer M, Franke U, Barz D, Marx G, Losche W. The value of rotation thromboelastometry to monitor disturbed perioperative haemostasis and bleeding risk in patients with cardiopulmonary bypass. Blood Coagul Fibrinolysis. 2008;19(3):212-219.
16. Sambu N, Curzen N. Monitoring the effectiveness of antiplatelet therapy: opportunities and limitations. Br J Clin Pharmacol. 2011;72(4):683-696.
17. Camenzind V, Bombeli T, Seifert B, et al. Citrate storage affects thrombelastograph analysis. Anesthesiology. 2000;92(5):1242-1249.
18. Khurana S, Mattson JC, Westley S, O'Neill WW, Timmis GC, Safian RD. Monitoring platelet glycoprotein IIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med. 1997;130(4):401-411.
19. Chavez JJ, Foley DE, Snider CC, et al. A novel thrombelastograph tissue factor/kaolin assay of activated clotting times for monitoring heparin anticoagulation during cardiopulmonary bypass. Anesth Analg. 2004;99(5):1290-1294.
20. Harding SA, Mallett SV, Peachey TD, Cox DJ. Use of heparinase modified thrombelastography in liver transplantation. Br J Anaesth. 1997;78(2):175-179.
21. Harr JN, Moore EE, Ghasabyan A, et al. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma. Shock. 2013;39(1):45-49.
22. Castellino FJ, Chapman MP, Donahue DL, et al. Traumatic brain injury causes platelet adenosine diphosphate and arachidonic acid receptor inhibition independent of hemorrhagic shock in humans and rats. J Trauma Acute Care Surg. 2014;76(5):1169-1176.
23. Bowbrick VA, Mikhailidis DP, Stansby G. The use of citrated whole blood in thromboelastography. Anesth Analg. 2000;90(5):1086-1088.
24. White H, Zollinger C, Jones M, Bird R. Can Thromboelastography performed on kaolin-activated citrated samples from critically ill patients provide stable and consistent parameters? Int J Lab Hematol. 2010;32(2):167-173.
25. Vig S, Chitolie A, Bevan DH, Halliday A, Dormandy J. Thromboelastog-raphy: a reliable test? Blood Coagul Fibrinolysis. 2001;12(7):555-561.
26. Johansson PI, Bochsen L, Andersen S, Viuff D. Investigation of the effect of kaolin and tissue-factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion. 2008;48(11):2377-2383.
27. Durila M, Lukas P, Bronsky J, Cvachovec K. Time impact on non-activated and kaolin-activated blood samples in thromboelastography. BMC Anesthesiol. 2015;15:50.
28. Zambruni A, Thalheimer U, Leandro G, Perry D, Burroughs AK. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis. 2004;15(1):103-107.
29. Wasowicz M, Srinivas C, Meineri M, Banks B, McCluskey SA, Karkouti K. Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples. Can J Anaesth. 2008;55(5):284-289.
30. Johansson PI, Stensballe J, Oliveri R, Wade CE, Ostrowski SR, Holcomb JB. How I treat patients with massive hemorrhage. Blood. 2014;124(20):3052-3058.
31. Hill JS, Devenie G, Powell M. Point-of-care testing of coagulation and fibrinolytic status during postpartum haemorrhage: developing a thrombelastog-raphy®-guided transfusion algorithm. Anaesth Intensive Care. 2012;40(6):1007-1015.
32. Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration. Am J Clin Pathol. 1998;109(5):595-599.
33. Chuang J, Sadler MA, Witt DM. Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-ml (pediatric) tubes. Chest. 2004;126(4):1262-1266.
34. Haemonetics. Timing of citrate samples [manufacturer letter]. Niles, IL: Haemonetics Corporation; 2012.
35. Breddin HK. Can platelet aggregometry be standardized? Platelets. 2005;16(3-4):151-158.
36. Kaiser AF, Neubauer H, Franken CC, Kruger JC, Mugge A, Meves SH. Which is the best anticoagulant for whole blood aggregometry platelet function testing?: comparison of six anticoagulants and diverse storage conditions. Platelets. 2012;23(5):359-367.
37. Khanna V, Hobson A, Mikael R, Sambu N, Englyst N, Curzen N. Does the VerifyNow P2Y12 assay overestimate "therapeutic response" to clopidogrel?: insights using short thrombelastography. Thromb Haemost. 2014;111(6):1150-1159.
38. Ben-Dor I, Kleiman NS, Lev E. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. Am J Cardiol. 2009;104(2):227-233.
39. Jin RC, Voetsch B, Loscalzo J. Endogenous mechanisms of inhibition of platelet function. Microcirculation. 2005;12(3):247-258.
40. Golanski J, Pietrucha T, Baj Z, Greger J, Watala C. Molecular insights into the anticoagulant-induced spontaneous activation of platelets in whole blood-various anticoagulants are not equal. Thromb Res. 1996;83(3):199-216.
41. Johnston LR, Larsen PD, La Flamme AC, Harding SA. Methodological considerations for the assessment of ADP induced platelet aggregation using the Multiplate® analyser. Platelets. 2013;24(4):303-307.
42. Glusa E. Platelet aggregation in recombinant-hirudin-anticoagulated blood. Haemostasis. 1991;21(suppl 1):1116-1120.
43. Haemonetics. Lithium heparin tubes validated for use with the Platelet-Mapping® assay on the TEG® hemostasis analyzer [manufacturer letter]. Niles, IL: Haemonetics Corporation; 2008.
44. Gerotziafas GT, Zarifis J, Bandi A, et al. Description of response to aspirin and clopidogrel in outpatients with coronary artery disease using multiple electrode impedance aggregometry. Clin Appl Thromb Hemost. 2012;18(4):356-363.